IRUXOL MONO OINTMENT

Product Information

Registration Status: Active

IRUXOL MONO OINTMENT is approved to be sold in Singapore with effective from 2003-09-19. It is marketed by SMITH & NEPHEW PTE LIMITED, with the registration number of SIN12427P.

This product contains Associated Proteases 0.24 u/g, and Clostridiopeptidase A 1.2 u/g in the form of OINTMENT. It is approved for TOPICAL use.

This product is manufactured by NORDMARK ARZNEIMITTEL GMBH & CO KG in GERMANY.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Associated Proteases
Clostridiopeptidase A


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.



Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank